Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Obesity × Ketorolac × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Pain, Postoperative 3 Pain 3 Agnosia 3 Inflammation 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Thyroid Nodule 1 Reperfusion Injury 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Obesity 1 Neoplasms 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Kidney Neoplasms 1 Ileus 1 Goiter 1 Fallopian Tube Neoplasms 1 End Stage Liver Disease 1 Emergencies 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Curative Breast Cancer Surgery 1 Constipation 1

Interventions

Exercise 23 Metformin 18 Tirzepatide 8 Diet 8 Resistance Training 7 Nutrition Assessment 7 Methods 7 Diet Therapy 7 Counseling 7 Early Intervention, Educational 6 Caloric Restriction 6 semaglutide 5 Exenatide 5 Diet, Mediterranean 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Liraglutide 4 Educational Status 4 Docosahexaenoic Acids 4 Bariatric Surgery 4 exemestane 3 Vitamin D 3 Therapeutics 3 Tamoxifen 3 Standard of Care 3 Observation 3 Naltrexone 3 Letrozole 3 Dexamethasone 3 Bupropion 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡